Transforming Cancer Research
Inside Our Laboratory
Explore cutting-edge oncology research and our state-of-the-art facilities
Platform Features
Comprehensive AI-driven tools for accelerated drug discovery
Single-Cell Analysis
Map tumor heterogeneity with unprecedented resolution. Understand every cell in the microenvironment.
Learn MoreDrug Response Simulation
Real-time IC50 predictions, synergy scoring, and patient avatar modeling before clinical trials.
Learn MoreQuantum Acceleration
100x faster molecular simulations using hybrid quantum-classical computing architecture.
Learn MoreMulti-Modality Pipeline
Small molecules, antibodies, and PROTACs. Comprehensive therapeutic coverage for all cancer types.
Learn MoreActive Pipeline
10+ novel targets across Phase I-III clinical trials with breakthrough potential.
Learn MoreExpert Team
World-class ML PhDs and clinical oncologists working together to transform drug discovery.
Learn MoreReady to Transform Drug Discovery?
Join leading pharmaceutical companies using our AI platform to accelerate oncology research and bring life-saving treatments to patients faster.
Industry Collaborations
Working with global Partners
Presenting at ASCO on advancing oncology drug discovery through AI and computation.
Our partnership with CHORDOMA to design novel small‑molecule ligands targeting TBXT in chordoma using our Cancer AI drug discovery work.
With Insilico Medicine, we co-create the future of AI-powered Oncology drug discovery.
Partnership with Mayo Clinic to advance AI-driven oncology drug discovery.
In partnership with NVIDIA, we leverage DGX supercomputing to accelerate AI-driven Oncology drug discovery.
Our partnership with Dr. Prem at the Icahn School of Medicine focuses on translating AI-powered drug discovery into oncology research.